claim: the study van den broek et al. (2016) [160] detailed the highest difference 10.3% between brca 1 and brca2 carriers.
article_headline: genetics of breast and gynecologic cancers (pdqa)ahealth professional version - national cancer institute
initial_claim: women with stage 4 breast cancer survive longer if they have surgery, study shows